Use access key #2 to skip to page content.
$69.08 -0.55 (-0.79%)
5/16/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

2

Avatar madiasha (< 20) Submitted: 5/03/07 1:09 PM : Outperform Start Price: $66.02 GENZ Score: 9.62

GENZ looks too much like a takeover target because of product and pipeline.Value is much more than present capitalization.

Report this Post Replies: 0 | Reply

Featured Broker Partners